Penpulimab plus anlotinib as second-line treatment for the small cell lung cancer after failure of platinum-based systemic chemotherapy.

被引：8
|
作者：
Zhang, Changgong
Yang, Sheng
Chen, Jianhua
Wu, Huijuan
Wang, Jun
Li, Yingping
Gao, Liying
Jia, Zhongyao
Sun, Yan
Zhao, Jun
Mu, Xin Lin
Bai, Chunmei
Wang, Rui
Wu, Kailiang
Liu, Qiang
Jin, Xiaoping
Tan, Xiaowen
Shi, Yuankai
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticancer Mol Targete, Natl Canc Center, Natl Clin Res,Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[4] Gansu Prov Canc Hosp, Lanzhou, Peoples R China
[5] Gansu Canc Hosp, Lanzhou, Peoples R China
[6] Linyi Peoples Hosp, Linyi, Shandong, Peoples R China
[7] Beijing Canc Hosp, Beijing, Peoples R China
[8] Peking Univ Peoples Hosp, Beijing, Peoples R China
[9] Peking Union Med, Coll Hosp, Dept Oncol, Beijing, Peoples R China
[10] Fourth Hosp Hebei Med Univ, Shijiazhuang, Hebei, Peoples R China
[11] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[12] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China
[13] Shenyang Chest Hosp, Shenyang, Peoples R China
[14] Akeso Biopharma Inc, Zhongshan, Peoples R China
[15] Chia Tai Tianqing Pharmaceut Grp Co Ltd, Dept Clin Med, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.8568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8568
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The combination therapy of anlotinib and penpulimab for the treatment of small cell lung cancer after platinum-based chemotherapy: Results of a phase II exploratory study
    Yang, Nong
    Zhang, Yongchang
    Zeng, Liang
    Yang, Haiyan
    Zhou, Chunhua
    Liu, Li
    Xiong, Yi
    Jiang, Wenjuan
    Wang, Zhan
    Zeng, Fanxu
    Chen, Qun
    Feng, Yuanqing
    Zhou, Chengzhi
    Wu, Zhijun
    Zhang, Bing
    Li, Xiantao
    Xiao, Maoliang
    Wang, Cunji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer
    Numico, G
    Merlano, M
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 331 - 333
  • [3] Outcomes of second-line chemotherapy in Japanese patients with small cell lung cancer previously treated with platinum-based chemotherapy
    Haruyasu, Murakami
    Naito, Tateaki
    Kaira, Kyoichi
    Tsuya, Asuka
    Nakamura, Yukiko
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S817 - S818
  • [4] Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens
    Kosmas, C
    Tsavaris, N
    Panopoulos, C
    Vadiaka, M
    Stavroyianni, N
    Kourelis, T
    Malamos, N
    Antonopoulos, M
    Kalofonos, HP
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) : 972 - 978
  • [5] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
    Yoon, S.
    Lee, D. H.
    Choi, C.
    Lee, J. C.
    Lee, J. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] TORIPALIMAB COMBINED WITH PLATINUM-BASED CHEMOTHERAPY AS A SECOND-LINE TREATMENT FOR SMALL CELL LUNG CANCER (SCLC) WITH BRAIN METASTASES: A CASE REPORT
    Fan, Jieqiong
    Zhang, Yao
    Mo, Xiaofei
    Guo, Jing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A662 - A662
  • [7] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 189 - 195
  • [8] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Mori, K.
    Kamiyama, Y.
    Kondo, T.
    Kodama, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 393 - 393
  • [9] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kondo, Tetsuro
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 189 - 195
  • [10] Platinum-Based Second-Line Treatment in Non-Small-Cell Lung Cancer: An Old New Kid on the Block?
    de Lima Araujo, Luiz Henrique
    Ferreira, Carlos G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : E24 - E25
12345